Carl Zeiss Meditec AG (CZMWY)
Carl Zeiss Meditec Statistics
Share Statistics
Carl Zeiss Meditec has 87.54M shares outstanding. The number of shares has increased by -2.08% in one year.
| Shares Outstanding | 87.54M |
| Shares Change (YoY) | -2.08% |
| Shares Change (QoQ) | 0.05% |
| Owned by Institutions (%) | 0% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 100 |
| FTD / Avg. Volume | 2.65% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 35.3 and the forward PE ratio is null. Carl Zeiss Meditec's PEG ratio is -0.93.
| PE Ratio | 35.3 |
| Forward PE | n/a |
| PS Ratio | 3.05 |
| Forward PS | n/a |
| PB Ratio | 3.09 |
| P/FCF Ratio | 66.33 |
| PEG Ratio | -0.93 |
Enterprise Valuation
Carl Zeiss Meditec has an Enterprise Value (EV) of 6.44B.
| EV / Sales | 3.12 |
| EV / EBITDA | 15.98 |
| EV / EBIT | 26.04 |
| EV / FCF | 67.71 |
Financial Position
The company has a current ratio of 2.13, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.13 |
| Quick Ratio | 1.19 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.38 |
| Debt / FCF | 1.59 |
| Interest Coverage | 6.61 |
Financial Efficiency
Return on Equity is 8.75% and Return on Invested Capital is 5.1%.
| Return on Equity | 8.75% |
| Return on Assets | 5.27% |
| Return on Invested Capital | 5.1% |
| Revenue Per Employee | $1,000,061.47 |
| Profits Per Employee | $86,508.23 |
| Employee Count | 2,066 |
| Asset Turnover | 0.61 |
| Inventory Turnover | 1.82 |
Taxes
| Income Tax | 60.71M |
| Effective Tax Rate | 25.21% |
Stock Price Statistics
The stock price has increased by -34.89% in the last 52 weeks. The beta is 1.23, so Carl Zeiss Meditec's price volatility has been higher than the market average.
| Beta | 1.23 |
| 52-Week Price Change | -34.89% |
| 50-Day Moving Average | 64.93 |
| 200-Day Moving Average | 63.21 |
| Relative Strength Index (RSI) | 57.13 |
| Average Volume (20 Days) | 3,770 |
Income Statement
In the last 12 months, Carl Zeiss Meditec had revenue of 2.07B and earned 178.73M in profits. Earnings per share was 2.01.
| Revenue | 2.07B |
| Gross Profit | 1.09B |
| Operating Income | 194.45M |
| Net Income | 178.73M |
| EBITDA | 403.06M |
| EBIT | 270.29M |
| Earnings Per Share (EPS) | 2.01 |
Balance Sheet
The company has 20.29M in cash and 151.35M in debt, giving a net cash position of -131.06M.
| Cash & Cash Equivalents | 20.29M |
| Total Debt | 151.35M |
| Net Cash | -131.06M |
| Retained Earnings | 1.49B |
| Total Assets | 3.39B |
| Working Capital | 643.65M |
Cash Flow
In the last 12 months, operating cash flow was 247.32M and capital expenditures -152.2M, giving a free cash flow of 95.11M.
| Operating Cash Flow | 247.32M |
| Capital Expenditures | -152.2M |
| Free Cash Flow | 95.11M |
| FCF Per Share | 1.07 |
Margins
Gross margin is 52.69%, with operating and profit margins of 9.41% and 8.65%.
| Gross Margin | 52.69% |
| Operating Margin | 9.41% |
| Pretax Margin | 11.66% |
| Profit Margin | 8.65% |
| EBITDA Margin | 19.51% |
| EBIT Margin | 9.41% |
| FCF Margin | 4.6% |
Dividends & Yields
CZMWY pays an annual dividend of $0.68, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | -47.68% |
| Payout Ratio | 33.82% |
| Earnings Yield | 2.83% |
| FCF Yield | 1.51% |
Analyst Forecast
Currently there are no analyst rating for CZMWY.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | 4.43 |
| Piotroski F-Score | 6 |